Nordea (Finland) This year one in three Finnish households plans to travel abroad on holiday. On average, households expect to spend 1,410 euros on their summer holidays, which is slightly less than in 2007. Last summer Finns estimated to spend 1,450 euros on their holidays. This information is derived from a Nordic survey commissioned by Nordea.
Photocure ASA Oslo, 10 June 2008 - PCI Biotech Holding ASA, the Norwegian drug delivery company with a focus on cancer therapeutics, today announced the successful closing of its initial public offering in connection with the listing of the PCI Biotech Holding ASA shares on Oslo Axess (the Share Issue). The offering price was NOK 20 per share. Gross proceeds amounted to NOK 60 million (Approximately USD 11.9 million). PCI Biotech Holding ASA shares are expected to begin trading on the Oslo Axess (ticker: PCIB) on Wednesday 18 June 2008.
PCI Biotech Holding Oslo, 10 June 2008 - PCI Biotech Holding ASA, the Norwegian drug delivery company with a focus on cancer therapeutics, today announced the successful closing of its initial public offering in connection with the listing of the PCI Biotech Holding ASA shares on Oslo Axess (the Share Issue). The offering price was NOK 20 per share. Gross proceeds amounted to NOK 60 million (Approximately USD 11.9 million). PCI Biotech Holding ASA shares are expected to begin trading on the Oslo Axess (ticker: PCIB) on Wednesday 18 June 2008.
ADVA AG Optical Networking ADVA Optical Networking heads metro-focused group in European public/private research initiative
Songa Offshore ASA The final day to convert warrants issued by Songa Offshore ASA was Monday 9 June 2008. All warrants converted were so at USD 1.50 per share / warrant.
Songa Offshore ASA Reference is made to item 13 on the agenda of the Annual General Meeting in the Company held on 26 May 2008. On the basis of the resolution passed, the Board has allocated options to buy shares in the Company to the following employees: Asbjørn Vavik, CEO, 300,000 shares Trond Christensen, COO, 300,000 shares Tom E. Jebsen, CFO, 300,000 shares The strike price is according to the resolution set at NOK 74.75 per share.
OncoMethylome Sciences OncoMethylome's Technology to Be Used in Merck's Clinical Trial Program with Cilengitide
© 2026 ABN Newswire. All Rights reserved.